Related references
Note: Only part of the references are listed.Non-viral nucleic acid delivery methods
Igor Slivac et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Molecular Interactions of Autophagy with the Immune System and Cancer
Yunho Jin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Systemic delivery of the tumor necrosis factor gene to tumors by a novel dual DNA-nanocomplex in a nanoparticle system
Vasundhara Shukla et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles
Ana Vanessa Nascimento et al.
ACTA BIOMATERIALIA (2017)
Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis
Qian Zhong et al.
MOLECULAR PHARMACEUTICS (2016)
Personalized medicine: the enabling role of nanotechnology
Inge K. Herrmann et al.
NANOMEDICINE (2016)
Polymeric Nanocarriers for Non-Viral Gene Delivery
Ling Li et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Next-Generation Sequencing Reveals Low-Dose Effects of Cationic Dendrimers in Primary Human Bronchial Epithelial Cells
Neus Feliu et al.
ACS NANO (2015)
Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls
Hideaki Nakamura et al.
EXPERT OPINION ON DRUG DELIVERY (2015)
Inhibition of autophagy protects against PAMAM dendrimers-induced hepatotoxicity
Yubin Li et al.
NANOTOXICOLOGY (2015)
Systemic use of tumor necrosis factor alpha as an anticancer agent
Nicholas J. Roberts et al.
Oncotarget (2015)
Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer
Prashant Kesharwani et al.
BIOMATERIALS (2014)
The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets
Steven L. Wood et al.
CANCER TREATMENT REVIEWS (2014)
Mad2 Checkpoint Gene Silencing Using Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles in Non-Small Cell Lung Cancer Model
Ana Vanessa Nascimento et al.
MOLECULAR PHARMACEUTICS (2014)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
A review of nanocarriers for the delivery of small interfering RNA
Prashant Kesharwani et al.
BIOMATERIALS (2012)
Tumor-Cell Death, Autophagy, and Immunity
Louis M. Weiner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Phase I Clinical Trial of Systemically Administered TUSC2(FUS1)-Nanoparticles Mediating Functional Gene Transfer in Humans
Charles Lu et al.
PLOS ONE (2012)
A Novel Peptide Probe for Imaging and Targeted Delivery of Liposomal Doxorubicin to Lung Tumor
Xiaofeng He et al.
MOLECULAR PHARMACEUTICS (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer
Michael S. Sabel et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Dendrimer toxicity: Let's meet the challenge
Keerti Jain et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Intratumoral Immunotherapy of Established Solid Tumors With Chitosan/IL-12
David A. Zaharoff et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress
Wei Wang et al.
NANOTECHNOLOGY (2009)
A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung Cancer
De-Kuan Chang et al.
PLOS ONE (2009)
PAMAM Nanoparticles Promote Acute Lung Injury by Inducing Autophagic Cell Death through the Akt-TSC2-mTOR Signaling Pathway
Chenggang Li et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2009)
Immunotherapy of cancer by IL-12-based cytokine combinations
Jonathan M. Weiss et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells
M. K. L. Fung et al.
BRITISH JOURNAL OF CANCER (2006)
Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer
T Fujiwara et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX (R) vaccine in advanced-stage non-small-cell lung cancer
J Nemunaitis et al.
CANCER GENE THERAPY (2006)
Overview of ribonucleotide reductase inhibitors: An appealing target in anti-tumour therapy
NMFSA Cerqueira et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo
I Ito et al.
CANCER GENE THERAPY (2004)
Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine
JS Choi et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma
R Salgia et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Regulator of G-protein signaling protein 2 modulates purinergic calcium and ciliary beat frequency responses in airway epithelia
MC Nlend et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer:: Results of a multicenter phase II study
M Schuler et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers
DS Shah et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-labelled polyamidoamine dendrimers in vivo
N Malik et al.
JOURNAL OF CONTROLLED RELEASE (2000)